Cargando…

Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma

Double-hit lymphoma is one of the most aggressive and refractory lymphoma subtypes with recurrent genetic abnormalities of MYC and BCL-2 or BCL6 rearrangement, leading to a poor prognosis in the present clinical practice. Therefore, new therapeutic strategies for eliminating double-hit lymphomas are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Liying, Chen, Kai, Huang, Wei, Jiang, Yuelong, Sun, Xihuan, Zhou, Yong, Li, Li, Li, Yin, Deng, Xianming, Xu, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799717/ https://www.ncbi.nlm.nih.gov/pubmed/35091546 http://dx.doi.org/10.1038/s41420-022-00833-9

Ejemplares similares

Rational targeted therapeutics for double-hit lymphoma
por: Azizian, Nancy G, et al.
Publicado: (2019)

PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron
por: Su, Jingyi, et al.
Publicado: (2022)

PIKfyve regulates melanosome biogenesis
por: Liggins, Marc C., et al.
Publicado: (2018)

Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma
por: Liu, Yuanhui, et al.
Publicado: (2019)

Advancing the management of double hit lymphoma
por: Landsburg, Daniel J.
Publicado: (2017)

Drug therapy for double-hit lymphoma
por: Phuoc, Vania, et al.
Publicado: (2019)

Altered pathways and targeted therapy in double hit lymphoma
por: Zhuang, Yuxin, et al.
Publicado: (2022)

The PIKfyve Inhibitor Apilimod: A Double-Edged Sword against COVID-19
por: Baranov, Maksim V., et al.
Publicado: (2020)

PIKfyve Regulation of Endosome-Linked Pathways
por: de Lartigue, Jane, et al.
Publicado: (2009)

PIKfyve promotes neuron self-preservation
por: Powell, Kendall
Publicado: (2009)

Roles of PIKfyve in multiple cellular pathways
por: Rivero-Ríos, Pilar, et al.
Publicado: (2022)

Identification of PIKfyve kinase as a target in multiple myeloma
por: de Campos, Cecilia Bonolo, et al.
Publicado: (2020)

Tolosa-Hunt Syndrome in Double-Hit Lymphoma
por: Peddi, Prakash, et al.
Publicado: (2015)

The Amyloid Precursor Protein Controls PIKfyve Function
por: Balklava, Zita, et al.
Publicado: (2015)

Targeting MYC and BCL2 by a natural compound for “double‐hit” lymphoma
por: Liu, Xiaoqian, et al.
Publicado: (2022)

Flow Cytometric Evaluation of Double/Triple Hit Lymphoma
por: Roth, Christine G., et al.
Publicado: (2016)

Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve
por: Li, Chungen, et al.
Publicado: (2023)

A novel PIKFYVE mutation in fleck corneal dystrophy
por: Kotoulas, Andreas, et al.
Publicado: (2011)

Loss of PIKfyve drives the spongiform degeneration in prion diseases
por: Lakkaraju, Asvin K K, et al.
Publicado: (2021)

Disruption of PIKFYVE causes congenital cataract in human and zebrafish
por: Mei, Shaoyi, et al.
Publicado: (2022)

Vaccination strategies, the power of the unmatched double hits
por: Al-Qaisi, Talal S, et al.
Publicado: (2023)

Double-hit lymphoma of the male breast: a case report
por: Elgaafary, Shaymaa, et al.
Publicado: (2020)

Clinical Significance of “Double-hit” and “Double-protein” expression in Primary Gastric B-cell Lymphomas
por: He, Miaoxia, et al.
Publicado: (2016)

Indolyl-Pyridinyl-Propenone-Induced Methuosis through the Inhibition of PIKFYVE
por: Cho, Hyelim, et al.
Publicado: (2018)

Selective elimination of pluripotent stem cells by PIKfyve specific inhibitors
por: Chakraborty, Arup R., et al.
Publicado: (2022)

Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens
por: Kim, Heyjin, et al.
Publicado: (2020)

Peripheral immune cell profiling of double-hit lymphoma by mass cytometry
por: Lei, Tao, et al.
Publicado: (2023)

Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
por: Huang, Sixia, et al.
Publicado: (2019)

Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer
por: Qiao, Yuanyuan, et al.
Publicado: (2021)

Establishment and characterization of a novel ‘double‐hit’ follicular lymphoma cell line, FL‐SJC
por: Chen, Min, et al.
Publicado: (2020)

Identification of novel PIKFYVE gene mutations associated with Fleck corneal dystrophy
por: Gee, Jessica A., et al.
Publicado: (2015)

Correction to Indolyl-Pyridinyl-Propenone-Induced Methuosis through the Inhibition of PIKFYVE
por: Cho, Hyelim, et al.
Publicado: (2018)

Loss of PIKfyve Causes Transdifferentiation of Dictyostelium Spores Into Basal Disc Cells
por: Yamada, Yoko, et al.
Publicado: (2021)

Reactive oxygen species prevent lysosome coalescence during PIKfyve inhibition
por: Saffi, Golam T., et al.
Publicado: (2021)

PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding
por: Soares, Alberto Carpinteiro, et al.
Publicado: (2021)

Double-hit lymphoma (rearrangements of MYC, BCL-2) during pregnancy: A case report
por: Xie, Fan, et al.
Publicado: (2021)

Ataxia's double hit
por: Leslie, Mitch
Publicado: (2010)

Of microspheres and microbes: A double-hit strategy for cancer immunotherapy
por: Brinkhoff, Benjamin, et al.
Publicado: (2014)

Cutaneous presentation of Double Hit Lymphoma: A Case Report With Review of the Literature
por: Khelfa, Yousef, et al.
Publicado: (2016)

Clinical Features and Immunophenotypes of Double-Hit Diffuse Large B-Cell Lymphoma
por: Wu, Cheng-Han, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pr3vh8kmgkebnqq0e7u9n217fn